| scholarly article | Q13442814 |
| P2093 | author name string | Jackson HC | |
| Heal DJ | |||
| Hutchins LJ | |||
| Mazurkiewicz SE | |||
| Needham AM | |||
| P2860 | cites work | 2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity | Q28259188 |
| Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication | Q28294257 | ||
| Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release | Q28339453 | ||
| Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability | Q34663159 | ||
| Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system | Q36731252 | ||
| Clinical studies with fluoxetine in obesity | Q36731273 | ||
| Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding | Q39099247 | ||
| Venlafaxine. A review of its pharmacology and therapeutic potential in depression | Q40513410 | ||
| Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors. | Q40918142 | ||
| Sibutramine: a novel new agent for obesity treatment | Q41026257 | ||
| The physiology and brain mechanisms of feeding | Q41172997 | ||
| Dexfenfluramine. An updated review of its therapeutic use in the management of obesity | Q41445495 | ||
| The contribution of metabolites to the rapid and potent down-regulation of rat cortical beta-adrenoceptors by the putative antidepressant sibutramine hydrochloride | Q44971989 | ||
| Sibutramine in weight control: a dose-ranging, efficacy study | Q47425497 | ||
| The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation | Q48163276 | ||
| [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments | Q48235129 | ||
| Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes | Q48357634 | ||
| LY248686, a new inhibitor of serotonin and norepinephrine uptake | Q48362104 | ||
| Effect of nisoxetine on uptake of catecholamines in synaptosomes isolated from discrete regions of rat brain | Q48366079 | ||
| Anorectic effect of fenfluramine isomers and metabolites: relationship between brain levels and in vitro potencies on serotonergic mechanisms | Q48579995 | ||
| An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats | Q49160845 | ||
| Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence. | Q52521666 | ||
| Serotoninergic manipulation, meal-induced satiety and eating pattern: effect of fluoxetine in obese female subjects. | Q52870426 | ||
| Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. | Q53950649 | ||
| Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists | Q68104683 | ||
| Anorectic properties of a new long acting serotonin uptake inhibitor | Q70835991 | ||
| Comparison of fluoxetine and placebo in the treatment of obesity | Q71556949 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | (RS)-sibutramine | Q424151 |
| P304 | page(s) | 1758-1762 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. | |
| P478 | volume | 121 |
| Q46121282 | 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats |
| Q38449992 | 5-hydroxytryptamine medications for the treatment of obesity |
| Q41894548 | A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents |
| Q46174200 | A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam |
| Q42972169 | Absence of sibutramine effect on spontaneous anxiety in rats. |
| Q34661571 | Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans |
| Q36452526 | Central nervous system biogenic amine targets for control of appetite and energy expenditure |
| Q44225215 | Cocaine-induced hypophagia and hyperlocomotion in rats are attenuated by prazosin. |
| Q35029193 | Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha2-adrenoceptors |
| Q47228069 | Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats |
| Q44152769 | Comparison of the thermogenic and hypophagic effects of sibutramine's metabolite 2 and other monoamine reuptake inhibitors |
| Q34701029 | Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype? |
| Q35613905 | Effects of exercise on brain functions in diabetic animal models |
| Q36982413 | Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats |
| Q44448574 | Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat. |
| Q46316802 | Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation |
| Q44028352 | Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine |
| Q33904891 | Enantioselective behavioral effects of sibutramine metabolites |
| Q35612374 | Enhanced motivation for food reward induced by stress and attenuation by corticotrophin-releasing factor receptor antagonism in rats: implications for overeating and obesity |
| Q43236354 | Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats |
| Q35971241 | Fluvoxamine attenuated endoplasmic reticulum stress-induced leptin resistance |
| Q24685521 | From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase |
| Q41819309 | High-fat diet-induced alterations in the feeding suppression of low-dose nisoxetine, a selective norepinephrine reuptake inhibitor. |
| Q47277856 | Hypothalamic serotonin in control of eating behavior, meal size, and body weight |
| Q47172455 | Idalopirdine, a selective 5-HT6 receptor antagonist, reduces food intake and body weight in a model of excessive eating. |
| Q45220342 | In vitro and in vivo effect of fluoxetine on the permeability of 3H-serotonin across rat intestine |
| Q38608673 | Lorcaserin Hcl for the treatment of obesity |
| Q74629242 | Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine |
| Q34486676 | Memantine reduces consumption of highly palatable food in a rat model of binge eating |
| Q73547215 | Modalities of the food intake-reducing effect of sibutramine in humans |
| Q35041626 | Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors. |
| Q37805802 | Modulatory role of serotonin on feeding behavior. |
| Q44183613 | Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight. |
| Q43919486 | Neonatal maternal deprivation modifies feeding in response to pharmacological and behavioural factors in adult rats |
| Q37939362 | Neuropsychiatric adverse effects of centrally acting antiobesity drugs. |
| Q42677386 | Pharmacological sensitivity of reflexive and nonreflexive outcomes as a correlate of the sensory and affective responses to visceral pain in mice |
| Q38017215 | Preclinical discovery of duloxetine for the treatment of depression. |
| Q43911362 | Regulation of body weight and carcass composition by sibutramine in rats |
| Q45908028 | Reversal of sibutramine-induced anorexia with a selective 5-HT(2C) receptor antagonist. |
| Q46185383 | Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake |
| Q47225467 | Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats |
| Q74238250 | Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine |
| Q73799836 | Sibutramine metabolites increase glucose transport by cultured rat muscle cells |
| Q28363106 | Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y |
| Q74272016 | Sibutramine, a serotonin uptake inhibitor, increases dopamine concentrations in rat striatal and hypothalamic extracellular fluid |
| Q51565817 | Sibutramine. A review of its contribution to the management of obesity. |
| Q28373048 | Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity |
| Q35029076 | Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats |
| Q46245138 | Successful duloxetine treatment of a binge eating disorder: a case report |
| Q58068053 | The Effect of Sibutramine, a Serotonin-Norepinephrine Reuptake Inhibitor, on Platelets and Fibrin Networks of Male Sprague-Dawley Rats: A Descriptive Study |
| Q34128195 | The discovery and status of sibutramine as an anti-obesity drug |
| Q34712327 | The use of serotonergic drugs to treat obesity--is there any hope? |
| Q35589958 | The utility of animal models to evaluate novel anti-obesity agents |
| Q35028643 | Thermogenic effects of sibutramine and its metabolites |
| Q33995120 | Tolerability and safety of fluvoxamine and other antidepressants |
| Q42474617 | Treatment effect of sibutramine compared to fluoxetine on leptin levels in polycystic ovary disease |
| Q43613518 | Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox. |
Search more.